- Home
- Nobeglar-Uno 100IU Prefilled Pen 3 ml
Nobeglar-Uno 100IU Prefilled Pen 3 ml Substitute
Nobeglar-Uno 100IU Prefilled Pen 3 ml Substitute
Verified Ingredients and Effects
Composition:
INSULIN GLARGINE-100IU
Uses:
<p>Nobeglar-Uno 100IU Prefilled Pen 3 ml used in the treatment of diabetes (Type 1 diabetes mellitus, Type 2 diabetes mellitus). The detailed uses of Nobeglar-Uno 100IU Prefilled Pen 3 ml are as follows:</p><ul><li><strong>Manage diabetes:</strong> Nobeglar-Uno 100IU Prefilled Pen 3 ml helps in managing both type 1 diabetes (adults and children) and type 2 diabetes (adults).</li><li><strong>Blood sugar level control:</strong> Nobeglar-Uno 100IU Prefilled Pen 3 ml controls blood sugar levels with a steady insulin release that replicates the body's natural insulin production.</li><li><strong>Long-acting Insulin Therapy: </strong>Nobeglar-Uno 100IU Prefilled Pen 3 ml provides steady insulin coverage for 24 hours, offering consistent blood sugar control without peaks and dips.</li><li><strong>Reduction of Hyperglycemia: </strong>Nobeglar-Uno 100IU Prefilled Pen 3 ml is involved in lowering high blood sugar levels, which helps in reducing the risk of diabetes complications like kidney damage and nerve damage.</li></ul>
Medicinal Benefits:
- Nobeglar-Uno 100IU Prefilled Pen 3 ml contains Insulin Glargine, a long-acting insulin used to improve glycemic control in adults and pediatric patients with type 1 diabetes mellitus and in adults with type 2 diabetes mellitus.
- It provides long-term blood sugar control by maintaining stable blood glucose levels throughout the day and night, reducing the risk of blood sugar spikes and drops.
- Insulin glargine is a man-made form of human insulin which helps replace the insulin that is normally produced by the body and moves sugar from the blood into other body tissues where it is used for energy. It also stops the liver from producing more sugar.
- By maintaining consistent insulin levels, Nobeglar-Uno 100IU Prefilled Pen 3 ml helps prevent diabetes-related complications such as nerve damage, kidney problems, and eye disease.
- Its long-acting formula provides a steady effect for up to 24 hours or more with a single daily injection, improving treatment adherence.
FAQs
Nobeglar-Uno 100IU Prefilled Pen 3 ml is used to treat type 1 diabetes in adults and children and type 2 diabetes mellitus in adults.
Nobeglar-Uno 100IU Prefilled Pen 3 ml works by replacing the insulin that is normally produced by the body. It helps move sugar from the blood into other body tissues where it is used for energy. Nobeglar-Uno 100IU Prefilled Pen 3 ml also prevents the liver from producing more sugar.
Nobeglar-Uno 100IU Prefilled Pen 3 ml should be stored in a refrigerator (2°C-8°C). Do not freeze.
Type-2 diabetes generally does not affect healthy children and teens, but it may affect children who are obese, which is also known as Childhood Obesity.
Cut back on foods high in sodium, alcohol, fried foods, and high-carb food and drinks like sugary drinks, drinks with added sugar, white rice and starchy vegetables.
Nobeglar-Uno 100IU Prefilled Pen 3 ml should not be discontinued without a doctor's consultation as stopping Nobeglar-Uno 100IU Prefilled Pen 3 ml may cause severe hypoglycaemia (low blood sugar) and ketoacidosis (buildup of acid in the blood). Consult the doctor if you feel uncomfortable after taking Nobeglar-Uno 100IU Prefilled Pen 3 ml.
The injection site should be changed to prevent skin changes like lumps under the skin. Nobeglar-Uno 100IU Prefilled Pen 3 ml may not work well if injected into the lumpy area.
Maintain a healthy diet and exercise regularly. Limit sugar intake and avoid smoking & alcohol consumption. Manage stress by doing meditation or yoga.
Hypoglycaemia (low blood sugar) may occur because you inject too much insulin, miss or delay meals, do not eat enough, eat food containing less carbohydrate than normal, drink alcohol, lose carbohydrates due to vomiting or diarrhoea, do more exercise than usual or a different type of physical activity, are recovering from an injury, illness, operation or stress, or are taking/have stopped taking other medicines.
Nobeglar-Uno 100IU Prefilled Pen 3 ml contains insulin glargine, a modified insulin which is very similar to human insulin.
Check the label for directions and use Nobeglar-Uno 100IU Prefilled Pen 3 ml as advised by the doctor. Talk to the doctor if you have any concerns. Fill the injection with the appropriate dose. Pick the injection site and wipe it with an alcohol swab. Now, pinch up the skin, inject the needle into the skin and then push the plunger in. After injecting the insulin, pull out the needle and dispose of the syringe safely.
Nobeglar-Uno 100IU Prefilled Pen 3 ml should be used only as prescribed by the doctor. The doctor will recommend the dose and duration based on your condition.
Using more than the prescribed dose of Nobeglar-Uno 100IU Prefilled Pen 3 ml may cause hypoglycaemia (low blood sugar). Monitor blood glucose levels and consult the doctor if the blood sugar levels are low.
The dose of Nobeglar-Uno 100IU Prefilled Pen 3 ml may need to be changed based on your blood sugar levels, lifestyle conditions, if are taking certain other medicines, during pregnancy, after giving birth, and breastfeeding.
Serious side effects of Nobeglar-Uno 100IU Prefilled Pen 3 ml include severe allergic reactions (rash/itching all over the body, severe swelling of skin or mucous membrane, shortness of breath, a fall in blood pressure with rapid heartbeat and sweating) and hypoglycaemia (thirst, tiredness, increased urge to urinate, tiredness, fast heartbeat, and low blood pressure). Seek immediate medical attention if you experience these symptoms.
Nobeglar-Uno 100IU Prefilled Pen 3 ml can be given to treat both the conditions of type 1 and type 2 diabetes mellitus. However, your doctor will decide whether Nobeglar-Uno 100IU Prefilled Pen 3 ml can be given to you or not, depending on your present condition. Nobeglar-Uno 100IU Prefilled Pen 3 ml should be avoided in patients who are allergic to Nobeglar-Uno 100IU Prefilled Pen 3 ml or other forms of insulin. It should be avoided in patients suffering from low potassium level (hypokalemia), moderate to severe kidney disease or liver disease. Inform the doctor if you are pregnant or breastfeeding.
